Literature DB >> 20714779

Transgenic mouse models of multiple sclerosis.

Tanja Scheikl1, Béatrice Pignolet, Lennart T Mars, Roland S Liblau.   

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating disease affecting the central nervous system (CNS) and a frequent cause of neurological disability in young adults. Multifocal inflammatory lesions in the CNS white matter, demyelination, oligodendrocyte loss, axonal damage, as well as astrogliosis represent the histological hallmarks of the disease. These pathological features of MS can be mimicked, at least in part, using animal models. This review discusses the current concepts of the immune effector mechanisms driving CNS demyelination in murine models. It highlights the fundamental contribution of transgenesis in identifying the mediators and mechanisms involved in the pathophysiology of MS models.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20714779     DOI: 10.1007/s00018-010-0481-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  270 in total

1.  Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid.

Authors:  Gregory P Owens; Alanna M Ritchie; Mark P Burgoon; R Anthony Williamson; John R Corboy; Donald H Gilden
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

2.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

3.  Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice.

Authors:  C Power; P A Kong; B D Trapp
Journal:  J Neurosci Res       Date:  1996-04-15       Impact factor: 4.164

4.  Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.

Authors:  C L Vanderlugt; K L Neville; K M Nikcevich; T N Eagar; J A Bluestone; S D Miller
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity.

Authors:  L B Nicholson; H Waldner; A M Carrizosa; A Sette; M Collins; V K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

6.  Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes.

Authors:  Julie Cabarrocas; Jan Bauer; Eliane Piaggio; Roland Liblau; Hans Lassmann
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

7.  Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development.

Authors:  J G Corbin; D Kelly; E M Rath; K D Baerwald; K Suzuki; B Popko
Journal:  Mol Cell Neurosci       Date:  1996-05       Impact factor: 4.314

8.  Negative feedback between prostaglandin and alpha- and beta-chemokine synthesis in human microglial cells and astrocytes.

Authors:  N Janabi; I Hau; M Tardieu
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

9.  Expression of monocyte chemoattractant protein-1 in brain tissue of patients with intractable epilepsy.

Authors:  Y Wu; X Wang; X Mo; Z Xi; F Xiao; J Li; X Zhu; G Luan; Y Wang; Y Li; J Zhang
Journal:  Clin Neuropathol       Date:  2008 Mar-Apr       Impact factor: 1.368

Review 10.  Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention.

Authors:  Roland S Liblau; F Susan Wong; Lennart T Mars; Pere Santamaria
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

View more
  3 in total

1.  Meet me halfway: when genomics meets structural bioinformatics.

Authors:  Sungsam Gong; Catherine L Worth; Tammy M K Cheng; Tom L Blundell
Journal:  J Cardiovasc Transl Res       Date:  2011-02-25       Impact factor: 4.132

Review 2.  Generation of genetically engineered non-human primate models of brain function and neurological disorders.

Authors:  Jung Eun Park; Afonso C Silva
Journal:  Am J Primatol       Date:  2018-12-26       Impact factor: 2.371

Review 3.  Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.

Authors:  Giuseppe Scalabrino
Journal:  Biomedicines       Date:  2022-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.